TBCRC 018: Phase II study of iniparib plus chemotherapy to treat triple- negative breast cancer (TNBC) brain metastases (BM) Meeting Abstract


Authors: Anders, C. K.; Nanda, R.; Liu, M. C.; Blackwell, K. L.; Van Poznak, C. H.; Abramson, V. G.; Storniolo, A. M.; Lin, N. U.; Stearns, V.; Melhem, A.; Puhalla, S.; Carpenter, J. T.; Melisko, M. E.; Deal, A. M.; Hudis, C.; Winer, E. P.; Perou, C. M.; Bradley, C. R.; Wolff, A. C.; Carey, L. A.; for the Translational Breast Cancer Research Consortium
Abstract Title: TBCRC 018: Phase II study of iniparib plus chemotherapy to treat triple- negative breast cancer (TNBC) brain metastases (BM)
Meeting Title: 47th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 29
Issue: 15 Suppl.
Meeting Dates: 2011 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2011-05-20
Language: English
ACCESSION: WOS:000208880304552
DOI: 10.1200/jco.2011.29.15_suppl.tps127
PROVIDER: wos
Notes: Meeting Abstract: TPS127 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Clifford Hudis
    905 Hudis